- Home
- ADIL
as 12-18-2024 2:30pm EST
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.
| Founded: | 2010 | Country: | United States |
| Employees: | N/A | City: | CHARLOTTESVILLE |
| Market Cap: | 6.5M | IPO Year: | 2018 |
| Target Price: | $8.00 | AVG Volume (30 days): | 206.3K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -3.41 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.77 - $4.17 | Next Earning Date: | 11-13-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Adial Pharmaceuticals Inc News
ADIL Breaking Stock News: Dive into ADIL Ticker-Specific Updates for Smart Investing
GlobeNewswire
15 days ago
Adial Pharmaceuticals Granted Key U.S. Patent for the Treatment of Alcohol and Drug Dependence Based on Expanded Genotype Combinations
Benzinga
15 days ago
EXCLUSIVE: Adial Pharmaceuticals' Lead Drug Secures Key US Patent For Alcohol Dependence Based on Expanded Genotype Combinations
PR Newswire
19 days ago
From kitchen waste to jet fuel: China's amazing energy solutions
Motley Fool
19 days ago
2 Social Security Cost-of-Living Adjustment (COLA) Changes Retirees Really Want to See
PR Newswire
19 days ago
Global Times: Exploring China's treasure trove of ethnic cultures
Simply Wall St.
19 days ago
Sosandar First Half 2025 Earnings: UK£0.003 loss per share (vs UK£0.005 loss in 1H 2024)
Simply Wall St.
19 days ago
Adler Group Third Quarter 2024 Earnings: EPS: €12.99 (vs €1.42 loss in 3Q 2023)
Simply Wall St.
19 days ago
Epwin Group's (LON:EPWN) investors will be pleased with their respectable 60% return over the last year
Compare ADIL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ADIL Adial Pharmaceuticals Inc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.